Kolon Life Science Stock Cash And Equivalents
| 102940 Stock | KRW 20,350 980.00 5.06% |
Kolon Life Science fundamentals help investors to digest information that contributes to Kolon Life's financial success or failures. It also enables traders to predict the movement of Kolon Stock. The fundamental analysis module provides a way to measure Kolon Life's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Kolon Life stock.
Kolon |
Kolon Life Science Company Cash And Equivalents Analysis
Kolon Life's Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.
Current Kolon Life Cash And Equivalents | 27.8 B |
Most of Kolon Life's fundamental indicators, such as Cash And Equivalents, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Kolon Life Science is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).
| Competition |
In accordance with the recently published financial statements, Kolon Life Science has 27.8 B in Cash And Equivalents. This is much higher than that of the Healthcare sector and significantly higher than that of the Pharmaceuticals industry. The cash and equivalents for all Republic of Korea stocks is significantly lower than that of the firm.
Kolon Cash And Equivalents Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Kolon Life's direct or indirect competition against its Cash And Equivalents to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Kolon Life could also be used in its relative valuation, which is a method of valuing Kolon Life by comparing valuation metrics of similar companies.Kolon Life is rated below average in cash and equivalents category among its peers.
Kolon Fundamentals
| Return On Equity | -6.82 | |||
| Return On Asset | -0.0218 | |||
| Profit Margin | (0.23) % | |||
| Operating Margin | (0.14) % | |||
| Current Valuation | 437.45 B | |||
| Shares Outstanding | 11.41 M | |||
| Shares Owned By Insiders | 35.61 % | |||
| Price To Earning | 286.10 X | |||
| Price To Sales | 3.32 X | |||
| Revenue | 165.49 B | |||
| Gross Profit | 18.74 B | |||
| EBITDA | (7.05 B) | |||
| Net Income | (1.37 B) | |||
| Cash And Equivalents | 27.8 B | |||
| Total Debt | 4.19 B | |||
| Debt To Equity | 16.60 % | |||
| Current Ratio | 1.08 X | |||
| Cash Flow From Operations | (16.19 B) | |||
| Target Price | 133333.0 | |||
| Number Of Employees | 422 | |||
| Beta | 1.34 | |||
| Market Capitalization | 397.58 B | |||
| Total Asset | 234.66 B | |||
| Retained Earnings | 77.45 B | |||
| Working Capital | 41.91 B | |||
| Current Asset | 83.96 B | |||
| Current Liabilities | 42.04 B | |||
| Z Score | 56.4 | |||
| Net Asset | 234.66 B |
About Kolon Life Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Kolon Life Science's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Kolon Life using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Kolon Life Science based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Kolon Life
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Kolon Life position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kolon Life will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Kolon Life could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Kolon Life when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Kolon Life - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Kolon Life Science to buy it.
The correlation of Kolon Life is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Kolon Life moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Kolon Life Science moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Kolon Life can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in Kolon Stock
Kolon Life financial ratios help investors to determine whether Kolon Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Kolon with respect to the benefits of owning Kolon Life security.